Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool

Use of Hepatitis C Viremic Donors to Expand the Pediatric Donor Pool

The use of hepatitis C virus (HCV)-positive donors in organ transplantation has become increasingly viable due to advancements in direct-acting antiviral (DAA) therapies, which offer high cure rates. This review aims to evaluate the current practices, benefits, and challenges of utilizing HCV-positi...

Full description

Saved in:
Bibliographic Details
Main Authors: Natasha Dilwali, Christopher Hartley, Paul K. Sue, Wikrom Karnsakul
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Pathogens
Subjects:
hepatitis C virus (HCV)
direct-acting antiviral (DAA) therapies
pediatric organ transplant
HCV-positive donors
Online Access:https://www.mdpi.com/2076-0817/13/11/947
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items